A detailed history of Abrdn PLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Abrdn PLC holds 232,385 shares of NVO stock, worth $19.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
232,385
Previous 241,384 3.73%
Holding current value
$19.8 Million
Previous $34.5 Million 19.69%
% of portfolio
0.05%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$119.07 - $145.42 $1.07 Million - $1.31 Million
-8,999 Reduced 3.73%
232,385 $27.7 Million
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $8,957 - $10,724
73 Added 0.03%
241,384 $34.5 Million
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $1.4 Million - $1.86 Million
13,679 Added 6.01%
241,311 $31 Million
Q4 2023

Jan 31, 2024

BUY
$87.78 - $105.45 $20 Million - $24 Million
227,632 New
227,632 $23.5 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.